Latest Strategy Changes News

Lloyds Banking Group reported a resilient start to 2025 with statutory profit after tax of £1.1 billion, underpinned by solid lending and deposit growth. The bank reaffirmed its 2025 guidance, maintaining confidence despite economic uncertainties.

Elixir Energy has successfully closed its Share Purchase Plan, raising an additional $117,000 and bringing total capital raised to $7.1 million, supported by new shares and free attaching options.

MCS Services Limited reported a solid cash position of $1.23 million at quarter-end and is actively exploring the sale of its Traffic Business subsidiary while awaiting key tender results.

Judo Capital Holdings updates its FY25 outlook, reporting stable margins and operational progress but slowing loan growth due to market uncertainties and higher provisioning.

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.

VanEck Investments Limited has released a replacement Product Disclosure Statement for six Australian bond ETFs, reflecting updated reference indices and market conditions effective May 1, 2025.

Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.

Pantoro Gold is set to become debt free by repaying its US$6.26 million Convertible Loan Facility ahead of schedule, reducing shareholder dilution and saving on interest payments.

Healius Limited has completed the $822 million cash sale of Lumus Imaging to Affinity Equity Partners, setting the stage for a strategic refocus on pathology and a substantial special dividend payout.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

WOTSO reports an 8% year-over-year revenue increase in Q3 FY25, driven by rising occupancy and expanding desk capacity. The company plans six new flexspace locations across Australia and New Zealand, balancing owned and leased properties.